Antibiotic use in pregnancy and drug-resistant infant sepsis

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 4, 1999, Pages 816-821

  Mercer, Brian M ^a   Carr, Teresa L ^a   Beazley, Dorothy D ^a   Crouse, Dennis T ^a   Sibai, Baba M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Antibiotic resistance; Antibiotics; Neonatal sepsis; Prematurity

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALEXIN; CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN; METRONIDAZOLE; NITROFURANTOIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SEPSIS; PREGNANCY; PREMATURE LABOR; PREMATURITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

EID: 0032694116     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70307-8     Document Type: Conference Paper

References (19)

1. 1. Romero R. Oyarzun E, Mazor M, Sirtori M, Hobbins JC, Bracken M. Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birthweight. Obstet Gynecol 1989;73:576-82.
2. 2. Smaill F. Antibiotic vs no treatment for asymptomatic bacteriuria. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Pregnancy and childbirth module of the Cochrane database of systematic reviews, 1995 [updated 1995 Feb 24]. London: BMJ Publishing Group; 1995.
3. 3. Amstey MS, Steadman KT. Symptomatic gonorrhea and pregnancy. J Am Vener Dis Assoc 1976;3:14-6.
4. 4. Holmes KK, Counts GW, Beaty HN. Disseminated gonococcal infection. Ann Intern Med 1971;74:979-93.
5. 5. Ryan GM, Abdella TN, McNeeley SG, Baselski VS, Drummond DE. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome. Am J Obstet Gynecol 1990;162:34-9.
6. 6. Centers for Disease Control and Prevention (CDC). 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998;47:1-111.
7. 7. Alger LS, Lovchik JC, Hebel JR, Blackmon LR, Crenshaw MC. The association of Chlamydia trachomatis, Neisseria gonorrhoeae, and group B streptococci with preterm rupture of the membranes and pregnancy outcome. Am J Obstet Gynecol 1988;159:397-404.
8. 8. Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized trial. JAMA 1997;278:989-95.
9. 9. American College of Obstetricians and Gynecologists. Premature rapture of the membranes. Clinical management guidelines for obstetrician-gynecologists. Washington: The College; 1998 Jun. p. 1-10. ACOG Practice Bulletin No: 1.
10. 10. Boyer KM, Gotoff SP. Prevention of early onset group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
11. 11. Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morb Mortal Wkly Rep 1996;45:1-24.
12. 12. Stiver HG, Forward KR, Tyrrell DL, Krip G, Livingstone RA, Fugere P, et al. Comparative cervical microflora shifts after cefoxitin or cefazolin prophylaxis against infection following cesarean section. Am J Obstet Gynecol 1984;149:718-21.
13. 13. McDuffie RS Jr, McGregor JA, Gibbs RS. Adverse perinatal outcome and resistant Enterobacteriaceac after antibiotic usage for premature rupture of the membranes and group B streptococcus carriage. Obstet Gynecol 1993;82:487-9.
14. 14. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread antepartal use of ampicillin. Am J Obstet Gynecol 1998;179:879-83.
15. 15. Mercer BM, Taylor M, Fricke J, Sibai B. The accuracy and patient preference for self-collected Group B streptococcus cultures. Am J Obstet Gynecol 1995;173:1325-8.
16. 16. American College of Obstetricians and Gynecologists Committee on Obstetric Practice. Prevention of early-onset group B streptococcal disease in newborns. Washington: The College; 1996. Committee Opinion No.: 173.
17. 17. MacGregor JA, French JI. Evidence-based prevention of preterm birth and rupture of membranes: infection and inflammation. J Soc Obstet Gynaecol Can 1997;19:835-52.
18. 18. Meis P, Goldenberg R, Iams J, Mercer B, Moawad A, McNellis D, et al. The preterm prediction study: significance of vaginal infections. Am J Obstet Gynecol 1995;173:1231-5.
19. 19. Barton L, Hodgman JE, Pavlova Z. Causes of death in the extremely low birth weight infant. Pediatrics 1999;103:446-51.